SCHEMBL16601376

SCHEMBL16601376

O=C(O)C1CCC(=O)N1Cc1ccccc1Br

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 7/20 0.59
HTT P42858 3/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
CYP2D6 P10635 4/20 0.45
CYP2C19 P33261 4/20 0.45
CYP2C9 P11712 3/20 0.45
CYP3A4 P08684 3/20 0.43
GFER P55789 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
CYP1A2 P05177 2/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16601374 1.00 P2RX7 (0.59) P2RX7HTTMAPTGAAMEN1
SCHEMBL7217950 0.84 HTT (0.48) P2RX7HTTMAPTGAAMEN1
SCHEMBL19974980 0.83 P2RX7 (0.62) P2RX7HTTMAPTGAAMEN1
SCHEMBL30062891 0.83 P2RX7 (0.62) P2RX7HTTMAPTGAAMEN1
SCHEMBL28316761 0.83 HTT (0.47) P2RX7HTTMAPTGAAMEN1
SCHEMBL289312 0.83 HTT (0.65) P2RX7HTTMAPTGAAMEN1
SCHEMBL1613003 0.83 CYP2D6 (0.48) P2RX7HTTMAPTGAAMEN1
SCHEMBL1613006 0.83 CYP2D6 (0.48) P2RX7HTTMAPTGAAMEN1
SCHEMBL1613178 0.83 HTT (0.65) P2RX7HTTMAPTGAAMEN1
SCHEMBL298888 0.81 HCRTR1 (0.59) P2RX7HTTMAPTGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052498-A1 3,7-DIAZABICYCLO[3.3.1]NONANE CARBOXAMIDES AS ANTITHROMBOTIC AGENTS Council of Scientific & Industrial Research (IN) 2016-08-10 EP disclosed
US-20160214983-A1 3,7-DIAZABICYCLO[3.3.1]NONANE CARBOXAMIDES AS ANTITHROMBOTIC AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-28 US disclosed
WO-2015044951-A1 3,7-DIAZABICYCLO[3.3.1 ]NONANE CARBOXAMIDES AS ANTITHROMBOTIC AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214983-A1 3,7-DIAZABICYCLO[3.3.1]NONANE CARBOXAMIDES AS ANTITHROMBOTIC AGENTS TBXA2R, PDGFRA, TBXAS1 P2RX7 87/4885HTT 2908/4885MAPT 4877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.